FR2201079A1 - Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities - Google Patents

Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities

Info

Publication number
FR2201079A1
FR2201079A1 FR7233704A FR7233704A FR2201079A1 FR 2201079 A1 FR2201079 A1 FR 2201079A1 FR 7233704 A FR7233704 A FR 7233704A FR 7233704 A FR7233704 A FR 7233704A FR 2201079 A1 FR2201079 A1 FR 2201079A1
Authority
FR
France
Prior art keywords
rotor
virus
viruses
impurities
prepn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7233704A
Other languages
French (fr)
Other versions
FR2201079B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST FRANCAIS D IMMUNOLOGIE
Original Assignee
INST FRANCAIS D IMMUNOLOGIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST FRANCAIS D IMMUNOLOGIE filed Critical INST FRANCAIS D IMMUNOLOGIE
Priority to FR7233704A priority Critical patent/FR2201079A1/en
Publication of FR2201079A1 publication Critical patent/FR2201079A1/en
Application granted granted Critical
Publication of FR2201079B1 publication Critical patent/FR2201079B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Centrifugal Separators (AREA)

Abstract

Viruses, antigens or purified vaccines are prepd. by fractional centrifugation of a crude virus conc. in a sterilised rotor (40-90% of vol. of rotor), spinning the rotor at 2000-5000 rev./min. and adding successively to the periphery of the rotor >=2 lots of liq of increasing density, the first being less dense than that of the virus particles but dense enough to prevent migration of the greater part of the impurities, and the density of the second being >= than that of the virus particles. Having completely filled with rotor it is accelerated to such a speed so as to separate the virus from the impurities, slowing the rotor to 2000-5000 rev./min. and introducing a liq. of density >= that of the contents of the bowl to discharge the contents through the central orifice of the rotor and collecting purified virus. Process is simple and cheap.
FR7233704A 1972-09-22 1972-09-22 Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities Granted FR2201079A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7233704A FR2201079A1 (en) 1972-09-22 1972-09-22 Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7233704A FR2201079A1 (en) 1972-09-22 1972-09-22 Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities

Publications (2)

Publication Number Publication Date
FR2201079A1 true FR2201079A1 (en) 1974-04-26
FR2201079B1 FR2201079B1 (en) 1975-10-31

Family

ID=9104676

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7233704A Granted FR2201079A1 (en) 1972-09-22 1972-09-22 Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities

Country Status (1)

Country Link
FR (1) FR2201079A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453651A1 (en) * 1979-04-10 1980-11-07 Schweiz Serum & Impfinst PROCESS FOR THE PREPARATION OF AN ANTIRABIC VACCINE AND VACCINE OBTAINED ACCORDING TO THIS PROCESS
WO1995010601A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
WO2009007608A1 (en) 2007-06-27 2009-01-15 Sanofi Pasteur Method for purifying a viral suspension
WO2013106548A1 (en) 2012-01-10 2013-07-18 The Broad Institute, Inc. Methods and cells for the production of viral vaccines
WO2023152429A1 (en) 2022-02-08 2023-08-17 Psa Automobiles Sa System for attaching batteries of different heights, vehicle and method based on such a system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL BIOCHEMISTRY, VOLUME 31, PAGES 255-271 1969 .) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453651A1 (en) * 1979-04-10 1980-11-07 Schweiz Serum & Impfinst PROCESS FOR THE PREPARATION OF AN ANTIRABIC VACCINE AND VACCINE OBTAINED ACCORDING TO THIS PROCESS
WO1995010601A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
US5792643A (en) * 1993-10-12 1998-08-11 Herrmann; Steven M. Methods for preserving recombinant retroviruses
WO2009007608A1 (en) 2007-06-27 2009-01-15 Sanofi Pasteur Method for purifying a viral suspension
WO2013106548A1 (en) 2012-01-10 2013-07-18 The Broad Institute, Inc. Methods and cells for the production of viral vaccines
WO2023152429A1 (en) 2022-02-08 2023-08-17 Psa Automobiles Sa System for attaching batteries of different heights, vehicle and method based on such a system

Also Published As

Publication number Publication date
FR2201079B1 (en) 1975-10-31

Similar Documents

Publication Publication Date Title
Steere Tobacco mosaic virus: purifying and sorting associated particles according to length
GB1282984A (en) Improvements in or relating to vaccines against viral hepatitis
FR2201079A1 (en) Viruses prepn. by fractional centrifugation - using liquids of graded densities to displace impurities
IE37455L (en) Separating particles from a liquid
US3396511A (en) Vortex separator for solid or liquid aerosols or the like
AU2711384A (en) Centrifuge rotor with spiral divisions
GB1470320A (en) Isotopically selective excitation from plural excited states
Anderson et al. Analytical techniques for cell fractions: XV. Rotor B-XXIX—A new high-resolution zonal centrifuge rotor for virus isolation and cell fractionation
Waldmeier An attempt at an identification of the M‐regions
Portman et al. Composition of subcellular constituents of aortic intima plus inner media isolated by differential and density gradient centrifugation
JPS54139167A (en) Axial-flow decanter-shaped centrifugal separator
Wild et al. A study of the heterogeneous 37s ribonucleic acid induced by foot-and-mouth-disease virus
ES429335A1 (en) Method of separating liquid drops from a gas stream
PACKER et al. MJ KOOMEN, IRENE S. GULLEDGE
JPS5679165A (en) Preparation of pigment ink for writing utensils
Kaushal A new species of Thecotheus (Pezizales) from the western Himalayas
USD188629S (en) Bottle
USD75643S (en) Design for a decanter
USD234998S (en) Decanter with lid or similar article
GB1111016A (en) Process for the purification of trioxane
VANVOORHIS Large(g, d) sorting networks(Large g, d sorting networks, using generalized divide-sort-merge strategy)
USD219858S (en) Table napkin
JPS5312777A (en) Centrifugal gas washing and separation apparatus
USD155334S (en) Design for a bicycle handlebar
Qin et al. Observation on Detection of Specific Immune-Complex in Hepatitis B with ELISA.

Legal Events

Date Code Title Description
TP Transmission of property